Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

emcure pharma

Tag: emcure pharma

Read all Latest developments, information and news on and about emcure pharma

Emcure Pharma is an Indian pharmaceutical company headquartered in Pune, Maharashtra. Emcure's product portfolio includes tablets, capsules, and injectables.

Senores boosts heart health portfolio with acquisition of USFDA approved Enalapril Tablets from Wockhardt

Emcure Pharma to acquire remaining stake in arm Zuventus Healthcare

Ruchika Sharma22 Jun 2025 4:15 PM IST

Pune: Emcure Pharmaceuticals has announced that its Board of Directors has approved to enter into agreement with minority shareholders of...

NPPA sets retail prices for 41 drugs, including 29 Fixed-Dose Combinations containing Empagliflozin or Sitagliptin

Ruchika Sharma5 Jun 2025 4:05 PM IST

New Delhi: In its 133rd meeting held on May 29, 2025, the National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 41...

Emcure Pharma Anil Kothiyal to resign as President - India Sales & Marketing

Ruchika Sharma4 Jun 2025 10:30 AM IST

Pune: Emcure Pharmaceuticals Limited has announced the resignation of Anil Kothiyal, President - India Sales & Marketing and Senior...

USFDA issues EIR for Emcure Pharma Pune API facility

Ruchika Sharma19 April 2025 12:15 PM IST

Pune: In a recent BSE filing, Emcure Pharma has informed that the Company has received the Establishment Inspection Report (EIR) from the...

Emcure Pharma European arm Tillomed buys strategic pharma portfolio from Manx for 19.7 million pounds

Ruchika Sharma4 April 2025 4:30 PM IST

Pune: Tillomed Laboratories Limited, a subsidiary of Emcure Pharmaceuticals Ltd. and a European pharma company, has entered into an Asset...

Emcure Pharma arm Gennova advances development of Nipah virus vaccine

Ruchika Sharma1 April 2025 3:20 PM IST

Pune: Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharmaceuticals Ltd., is advancing the development of a pathbreaking...

Emcure Pharma Pune facility gets 2 USFDA observations

Ruchika Sharma26 Feb 2025 3:14 PM IST

Pune: Emcure Pharmaceuticals Limited has announced that the Company has received two observations in Form 483 from the United States Food and...

Emcure Pharma inaugurates RnD centre in Gujarat

Ruchika Sharma23 Jan 2025 11:00 AM IST

Ahmedabad: Emcure Pharmaceuticals Limited has announced the inauguration of its state-of-the-art Formulation Research and Development (R&D) Centre...

Keshav Bhutada becomes CEO of Shilpa Pharma Life Sciences

Gufic Biosciences appoints Dr Kathiresan Rajasekar as President - International Business, Senior Management Personnel

Ruchika Sharma17 Jan 2025 1:50 PM IST

Karnataka: Gufic Biosciences has announced the appointment of Dr Kathiresan Rajasekar as President – International Business, Senior Management...

Shares of Emcure Pharma surges over 31 percent in debut trade

Ruchika Sharma11 July 2024 12:30 PM IST

New Delhi: Shares of Emcure Pharmaceuticals Ltd made a debut on Wednesday as they listed with a significant premium of over 31 percent against...

Emcure Pharma set to launch IPO on July 3

Ruchika Sharma30 Jun 2024 10:15 AM IST

Emcure Pharmaceuticals, backed by Bain Capital, is set to float its Initial Public Offering (IPO) on July 3. The initial share sale will run until...

Emcure Pharma receives SEBI nod to float IPO

Ruchika Sharma25 Jun 2024 3:49 PM IST

Emcure Pharmaceuticals, backed by Bain Capital has received approval from Securities and Exchange Board of India's (SEBI) to raise...

Journal Club Today

Health News Today

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok